The integration process will allow for Quipt's best-in-class subscription-based resupply program to be firmly cemented creating an immediate revenue synergy. Moreover, NorCal Respiratory has strong diversification amongst referral sources, and its payor base. Under the terms of the definitive purchase agreement, Quipt acquired NorCal Respiratory for approximately $3.1 ‎million in cash. It is expected the acquisition will increase Quipt's annual revenues by approximately $3.2 million, and, post integration, Adjusted EBITDA by $650,000.